Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-03

Clinical Trial Update: XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing XELOX/mFOLFOX plus Vitamin D3 versus XELOX/mFOLFOX alone as first-line chemotherapy in metastatic colorectal cancer is ongoing with st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)
  • XELOX (capecitabine + oxaliplatin)
  • mFOLFOX

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Vitamin D3 | Phase 3 | Status: UNKNOWN